These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 24521426

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients.
    Hicks BM, Murray LJ, Hughes C, Cardwell CR.
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):830-40. PubMed ID: 26017274
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Angiotensin receptor blockers (ARB) outperform angiotensin-converting enzyme (ACE) inhibitors on ischemic stroke prevention in patients with hypertension and diabetes - A real-world population study in Taiwan.
    Pai PY, Muo CH, Sung FC, Ho HC, Lee YT.
    Int J Cardiol; 2016 Jul 15; 215():114-9. PubMed ID: 27111172
    [Abstract] [Full Text] [Related]

  • 5. Do outpatient statins and ACEIs/ARBs have synergistic effects in reducing the risk of pneumonia? A population-based case-control study.
    Kang JH, Kao LT, Lin HC, Wang TJ, Yang TY.
    PLoS One; 2018 Jul 15; 13(6):e0199981. PubMed ID: 29953536
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study.
    Mansfield KE, Nitsch D, Smeeth L, Bhaskaran K, Tomlinson LA.
    BMJ Open; 2016 Dec 21; 6(12):e012690. PubMed ID: 28003286
    [Abstract] [Full Text] [Related]

  • 8. Combined use of renin-angiotensin-aldosterone system-acting agents: a cross-sectional study.
    Farcas A, Leucuta D, Bucsa C, Mogosan C, Dumitrascu D.
    Int J Clin Pharm; 2016 Dec 21; 38(6):1390-1397. PubMed ID: 27677980
    [Abstract] [Full Text] [Related]

  • 9. Renin-angiotensin system inhibitors and risk of fractures: a prospective cohort study and meta-analysis of published observational cohort studies.
    Kunutsor SK, Blom AW, Whitehouse MR, Kehoe PG, Laukkanen JA.
    Eur J Epidemiol; 2017 Nov 21; 32(11):947-959. PubMed ID: 28752198
    [Abstract] [Full Text] [Related]

  • 10. Long term use of drugs affecting the renin-angiotensin system and the risk of cancer: a population-based case-control study.
    Hallas J, Christensen R, Andersen M, Friis S, Bjerrum L.
    Br J Clin Pharmacol; 2012 Jul 21; 74(1):180-8. PubMed ID: 22243442
    [Abstract] [Full Text] [Related]

  • 11. Effect of Renin-Angiotensin-Aldosterone System Inhibitors on Short-Term Mortality After Sepsis: A Population-Based Cohort Study.
    Hsu WT, Galm BP, Schrank G, Hsu TC, Lee SH, Park JY, Lee CC.
    Hypertension; 2020 Feb 21; 75(2):483-491. PubMed ID: 31838905
    [Abstract] [Full Text] [Related]

  • 12. Long-term use of angiotensin receptor blockers and the risk of cancer.
    Azoulay L, Assimes TL, Yin H, Bartels DB, Schiffrin EL, Suissa S.
    PLoS One; 2012 Feb 21; 7(12):e50893. PubMed ID: 23251399
    [Abstract] [Full Text] [Related]

  • 13. Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy.
    Steely AM, Callas PW, Bertges DJ, Vascular Study Group of New England.
    J Vasc Surg; 2016 Mar 21; 63(3):715-21. PubMed ID: 26603543
    [Abstract] [Full Text] [Related]

  • 14. Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink.
    Mahmoudpour SH, Baranova EV, Souverein PC, Asselbergs FW, de Boer A, Maitland-van der Zee AH, PREDICTION-ADR consortium.
    Br J Clin Pharmacol; 2016 Dec 21; 82(6):1647-1659. PubMed ID: 27524468
    [Abstract] [Full Text] [Related]

  • 15. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
    Trifirò G, Massari M, Da Cas R, Menniti Ippolito F, Sultana J, Crisafulli S, Giorgi Rossi P, Marino M, Zorzi M, Bovo E, Leoni O, Ludergnani M, Spila Alegiani S, ITA-COVID-19: RAAS inhibitor group.
    Drug Saf; 2020 Dec 21; 43(12):1297-1308. PubMed ID: 32852721
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis.
    Lo KB, Bhargav R, Salacup G, Pelayo J, Albano J, McCullough PA, Rangaswami J.
    Expert Rev Cardiovasc Ther; 2020 Dec 21; 18(12):919-930. PubMed ID: 32945216
    [Abstract] [Full Text] [Related]

  • 17. Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With a Reduced Risk of Poststroke Epilepsy in Patients With Ischemic Stroke.
    Chang KC, Lin CH, Huang JA.
    J Am Heart Assoc; 2024 Sep 03; 13(17):e035438. PubMed ID: 39189618
    [Abstract] [Full Text] [Related]

  • 18. Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study.
    Shen JI, Saxena AB, Vangala S, Dhaliwal SK, Winkelmayer WC.
    BMC Nephrol; 2017 Jun 17; 18(1):196. PubMed ID: 28623899
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
    Zhang Y, He D, Zhang W, Xing Y, Guo Y, Wang F, Jia J, Yan T, Liu Y, Lin S.
    Drugs; 2020 Jun 17; 80(8):797-811. PubMed ID: 32333236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.